Home › Research › Topics › fluid-biomarkers
fluid-biomarkers
6 studies tagged fluid-biomarkers, dated 2020-05-11 to 2024-03-27. Bibliography: BibTeX (.bib) · RIS (.ris)
Newest in this topic
Studies
6 studies carry this tag.
Date range
2020 to 2024
Top journals
- Annals of clinical and translational neurology 1
- Brain : a journal of neurology 1
- Continuum (Minneapolis, Minn.) 1
- Diagnostics (Basel, Switzerland) 1
- Journal of neurology, neurosurgery, and psychiatry 1
6 journals in all.
Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.
-
An improved understanding of the pathobiology of Alzheimer's disease (AD) should lead ultimately to an earlier and more accurate diagnosis of AD, providing the opportunity to intervene earlier in the disease process and to improve outcomes.
-
Plasma biomarkers of neuronal injury and astrogliosis are associated with reduced axonal density and region-specific myelin content.
-
After analytical validation, the diagnostic performance of these biomarkers was evaluated in CSF and compared with the Innotest total tau (and as proof of concept, with N-p-tau181 and N-p-tau217) in three clinical cohorts (n = 342 total).
-
CSF and blood-based biomarkers can evaluate for a range of neurologic disorders that are associated with dementia, including AD.
-
The frontotemporal dementia (FTD) spectrum of neurodegenerative disorders includes a heterogeneous group of conditions.
-
Several promising novel biomarkers were highlighted in this review.